Edwards Lifesciences Up Over 7%, on Pace for Largest Percent Increase Since November 2020 — Data Talk
Edwards Lifesciences Corporation (EW) is currently at $84.52, up $5.82 or 7.39%
--Would be highest close since July 26, 2023, when it closed at $91.63
--On pace for largest percent increase since Nov. 9, 2020, when it rose 7.65%
--Currently up four of the past five days
--Currently up three consecutive days; up 14.38% over this period
--Best three day stretch since the three days ending March 26, 2020, when it rose 26.85%
--Up 10.85% year-to-date
--Down 35.32% from its all-time closing high of $130.68 on Dec. 30, 2021
--Up 2.93% from 52 weeks ago (Feb. 3, 2023), when it closed at $82.12
--Down 10.39% from its 52-week closing high of $94.33 on June 30, 2023
--Up 36.97% from its 52-week closing low of $61.71 on Oct. 27, 2023
--Traded as high as $85.27; highest intraday level since July 27, 2023, when it hit $87.24
--Up 8.33% at today's intraday high; largest intraday percent increase since Nov. 9, 2020, when it rose as much as 10%
--Third best performer in the S&P 500 today
All data as of 1:00:47 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 02, 2024 13:17 ET (18:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
How to Invest Like Warren Buffett
-
Cognizant Earnings: Improved Profitability Buttresses Results as Customer Spending Remains Muted
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?